West Pharmaceutical Services Book Value Per Share Growth & History (WST)
West Pharmaceutical Services's book value per share was $44.11 for fiscal 2025.
View full West Pharmaceutical Services company overviewWest Pharmaceutical Services annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $44.11 | $7.01 | +18.90% |
| 2024 | 2024-12-31 | $37.10 | -$2.10 | −5.35% |
| 2023 | 2023-12-31 | $39.20 | $2.96 | +8.18% |
| 2022 | 2022-12-31 | $36.23 | $4.76 | +15.12% |
| 2021 | 2021-12-31 | $31.47 | $6.41 | +25.59% |
| 2020 | 2020-12-31 | $25.06 | $3.83 | +18.04% |
| 2019 | 2019-12-31 | $21.23 | $2.39 | +12.67% |
| 2018 | 2018-12-31 | $18.84 | $1.52 | +8.80% |
| 2017 | 2017-12-31 | $17.32 | $2.03 | +13.29% |
| 2016 | 2016-12-31 | $15.29 | $1.13 | +7.95% |
| 2015 | 2015-12-31 | $14.16 | $0.74 | +5.52% |
| 2014 | 2014-12-31 | $13.42 | $0.51 | +3.94% |
| 2013 | 2013-12-31 | $12.91 | $2.29 | +21.52% |
| 2012 | 2012-12-31 | $10.63 | $0.91 | +9.35% |
| 2011 | 2011-12-31 | $9.72 | $0.32 | +3.42% |
| 2010 | 2010-12-31 | $9.39 | $0.62 | +7.07% |
| 2009 | 2009-12-31 | $8.77 | $1.26 | +16.73% |
| 2008 | 2008-12-31 | $7.52 | — | — |
West Pharmaceutical Services quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $42.47 | $1.74 | +4.26% |
| Q1 2026 | 2026-03-31 | $42.18 | $4.81 | +12.87% |
| Q4 2025 | 2025-12-31 | $44.11 | $7.01 | +18.90% |
| Q3 2025 | 2025-09-30 | $42.44 | $4.48 | +11.80% |
| Q2 2025 | 2025-06-30 | $40.74 | $5.25 | +14.78% |
| Q1 2025 | 2025-03-31 | $37.37 | $0.65 | +1.77% |
| Q4 2024 | 2024-12-31 | $37.10 | -$2.10 | −5.35% |
| Q3 2024 | 2024-09-30 | $37.96 | -$0.80 | −2.06% |
| Q2 2024 | 2024-06-30 | $35.49 | -$1.67 | −4.51% |
| Q1 2024 | 2024-03-31 | $36.72 | -$0.69 | −1.86% |
| Q4 2023 | 2023-12-31 | $39.20 | $2.96 | +8.18% |
| Q3 2023 | 2023-09-30 | $38.76 | $5.37 | +16.08% |
| Q2 2023 | 2023-06-30 | $37.17 | $4.41 | +13.45% |
| Q1 2023 | 2023-03-31 | $37.42 | $6.02 | +19.18% |
| Q4 2022 | 2022-12-31 | $36.23 | $4.76 | +15.12% |
| Q3 2022 | 2022-09-30 | $33.39 | $3.67 | +12.34% |
| Q2 2022 | 2022-06-30 | $32.76 | $5.29 | +19.28% |
| Q1 2022 | 2022-03-31 | $31.39 | $6.61 | +26.67% |
| Q4 2021 | 2021-12-31 | $31.47 | $6.41 | +25.59% |
| Q3 2021 | 2021-09-30 | $29.72 | $6.46 | +27.78% |
| Q2 2021 | 2021-06-30 | $27.47 | $5.70 | +26.20% |
| Q1 2021 | 2021-03-31 | $24.78 | $4.54 | +22.40% |
| Q4 2020 | 2020-12-31 | $25.06 | $3.83 | +18.04% |
| Q3 2020 | 2020-09-30 | $23.26 | $3.16 | +15.70% |
| Q2 2020 | 2020-06-30 | $21.77 | $2.16 | +11.00% |
| Q1 2020 | 2020-03-31 | $20.25 | $1.61 | +8.67% |
| Q4 2019 | 2019-12-31 | $21.23 | $2.39 | +12.67% |
| Q3 2019 | 2019-09-30 | $20.10 | $1.86 | +10.19% |
| Q2 2019 | 2019-06-30 | $19.61 | $2.17 | +12.43% |
| Q1 2019 | 2019-03-31 | $18.63 | $0.90 | +5.06% |
| Q4 2018 | 2018-12-31 | $18.84 | $1.52 | +8.80% |
| Q3 2018 | 2018-09-30 | $18.24 | $0.52 | +2.93% |
| Q2 2018 | 2018-06-30 | $17.44 | $0.65 | +3.88% |
| Q1 2018 | 2018-03-31 | $17.74 | $1.86 | +11.70% |
| Q4 2017 | 2017-12-31 | $17.32 | $2.03 | +13.29% |
| Q3 2017 | 2017-09-30 | $17.72 | $2.12 | +13.58% |
| Q2 2017 | 2017-06-30 | $16.79 | $1.63 | +10.78% |
| Q1 2017 | 2017-03-31 | $15.88 | $1.19 | +8.07% |
| Q4 2016 | 2016-12-31 | $15.29 | $1.13 | +7.95% |
| Q3 2016 | 2016-09-30 | $15.61 | $1.80 | +13.04% |
| Q2 2016 | 2016-06-30 | $15.16 | $1.41 | +10.29% |
| Q1 2016 | 2016-03-31 | $14.69 | $1.60 | +12.25% |
| Q4 2015 | 2015-12-31 | $14.16 | $0.74 | +5.52% |
| Q3 2015 | 2015-09-30 | $13.80 | $0.16 | +1.17% |
| Q2 2015 | 2015-06-30 | $13.74 | $0.00 | +0.03% |
| Q1 2015 | 2015-03-31 | $13.09 | -$0.15 | −1.13% |
| Q4 2014 | 2014-12-31 | $13.42 | $0.51 | +3.94% |
| Q3 2014 | 2014-09-30 | $13.64 | $1.64 | +13.66% |
| Q2 2014 | 2014-06-30 | $13.74 | $2.50 | +22.25% |
| Q1 2014 | 2014-03-31 | $13.24 | $2.45 | +22.75% |
| Q4 2013 | 2013-12-31 | $12.91 | $2.29 | +21.52% |
| Q3 2013 | 2013-09-30 | $12.00 | $1.50 | +14.24% |
| Q2 2013 | 2013-06-30 | $11.24 | $1.25 | +12.57% |
| Q1 2013 | 2013-03-31 | $10.78 | $0.53 | +5.17% |
| Q4 2012 | 2012-12-31 | $10.63 | $0.91 | +9.35% |
| Q3 2012 | 2012-09-30 | $10.51 | $0.26 | +2.50% |
| Q2 2012 | 2012-06-30 | $9.98 | -$0.35 | −3.41% |
| Q1 2012 | 2012-03-31 | $10.25 | $0.35 | +3.57% |
| Q4 2011 | 2011-12-31 | $9.72 | $0.32 | +3.42% |
| Q3 2011 | 2011-09-30 | $10.25 | $0.76 | +8.01% |
| Q2 2011 | 2011-06-30 | $10.33 | $0.70 | +7.22% |
| Q1 2011 | 2011-03-31 | $9.90 | — | — |
| Q4 2010 | 2010-12-31 | $9.39 | $0.62 | +7.07% |
| Q3 2010 | 2010-09-30 | $9.49 | — | — |
| Q2 2010 | 2010-06-30 | $9.64 | — | — |
| Q4 2009 | 2009-12-31 | $8.77 | — | — |
West Pharmaceutical Services book value per share trends
Over the last five fiscal years, West Pharmaceutical Services's book value per share increased from $25.06 to $44.11, a change of $19.05. The latest reported quarter, Q2 2026, shows $42.47.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review West Pharmaceutical Services source filings ↗